Sempreon financials
$17.00−3.74%
Close Nov 12, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $736.3K | $1.7M | $4.7M | $3.0M | $1.3M | $1.1M | $3.1M |
| Gross profit | $408.9K | $1.2M | $3.2M | $1.8M | $227.1K | $271.9K | $339.8K |
| Gross margin | 55.5% | 68.3% | 68.5% | 61.3% | 17.2% | 24.9% | 11.0% |
| Operating income | -$14.8M | -$64.3M | -$123.7M | -$1.1M | -$6.6M | -$2.5M | -$8.3M |
| Net income | -$15.5M | -$66.8M | -$322.8M | $196.1M | -$8.5M | -$3.3M | -$5.2M |
| Net margin | −2111.0% | −3903.7% | −6844.5% | 6559.6% | −641.1% | −298.1% | −169.4% |
| Diluted EPS | $-13.30 | $-134.70 | $-294.91 | $339.40 | $-308.12 | $-135.34 | $-105.71 |
| EBITDA | -$14.8M | -$64.0M | -$120.1M | -$886.8K | -$6.4M | -$2.2M | -$8.0M |
| Operating cash flow | -$1.6M | -$2.5M | -$7.5M | -$4.3M | -$697.7K | -$2.0M | -$5.0M |
| Free cash flow | -$1.6M | -$2.5M | -$7.5M | -$4.3M | -$708.9K | -$2.0M | -$5.1M |
| Diluted shares | 1.2M | 0.5M | 1.1M | 0.6M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.4K | $92.7K | $245.3K | $1.7M | $186.0K | $99.5K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.7M | $2.7M | $2.7M | $2.7M | $13.2M | $13.1M |
| Total assets | $29.6M | $42.8M | $108.8M | $482.8M | $26.5M | $27.1M |
| Total liabilities | $11.3M | $10.4M | $10.5M | $62.3M | $29.4M | $27.4M |
| Shareholders' equity | $18.3M | $32.4M | $98.2M | $420.4M | -$2.9M | -$329.0K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology